McMaster University

Brain Cancer Canada Awards CAD 80,000 Grant to Fund Innovative Glioblastoma Research

Retrieved on: 
Thursday, May 11, 2023
Canada, GBM, Survival, CAD, Research, Brain, Glioblastoma, Government, McMaster University, Patient, Nature, Partnership, Medical imaging

TORONTO, May 11, 2023 (GLOBE NEWSWIRE) -- Brain Cancer Canada, a leading charity dedicated to funding research and technology for breakthrough treatments for brain cancer patients, has awarded a CAD 80,000 research grant to Dr. Sheila Singh and her team at McMaster University.

Key Points: 
  • TORONTO, May 11, 2023 (GLOBE NEWSWIRE) -- Brain Cancer Canada, a leading charity dedicated to funding research and technology for breakthrough treatments for brain cancer patients, has awarded a CAD 80,000 research grant to Dr. Sheila Singh and her team at McMaster University.
  • “This seed funding from Brain Cancer Canada and its partners will allow us to advance our research, and help transform the treatment landscape for future glioblastoma patients.”
    Angela Scalisi, Chair of Brain Cancer Canada, highlights the need for more research funding in this area.
  • “We encourage the Canadian government to join us in investing in groundbreaking research that can lead to life-changing treatments for brain cancer patients.”
    This grant is the second of five Brain Cancer Canada will issue in May 2023 as part of the Gray in May brain cancer awareness month campaign.
  • By providing crucial funding for high-risk, high-reward projects like Dr. Singh's, Brain Cancer Canada aims to accelerate the development of new therapies and improve the lives of those affected by brain cancer.

We can uphold the solidarity created by COVID-19 even though WHO ended the international emergency

Retrieved on: 
Thursday, May 11, 2023
Vaccine, Volunteering, Food, University, Awareness, Life, Vaccination, Personal protective equipment, Disability, Politics, COVID-19, Long-term care, Light, Prescription, Air travel, COVID, Carbon, Movement, Government, Thought, Pain, Disaster, Social justice, University of Guelph, Hospital, McMaster University, Time, Motivation, WHO, Immunodeficiency, News, Tourism, Pharmaceutical industry

The World Heath Organization (WHO) has declared the end of the global emergency caused by the COVID-19 pandemic.

Key Points: 
  • The World Heath Organization (WHO) has declared the end of the global emergency caused by the COVID-19 pandemic.
  • Although COVID-19 remains a danger for many, especially with the possibility of new variants, experts are urging that we move forward to prepare for the next pandemic.
  • But the pandemic also created the circumstances for a type of global, national and local solidarity that has rarely been seen before.

Caremongering

    • A study led by researchers at McMaster University on caremongering Facebook groups found that the majority of posts were to request or offer materials like personal protective equipment, food and clothes or services like picking up groceries and prescriptions.
    • There was also a lot of information-sharing about COVID-19, community updates, inspiration and advice.

Pandemic unveiled systemic issues

    • Disasters like the pandemic provide an opportunity to examine the exception in order to understand the rule and to expose the unequal social structures that are often hidden in everyday life.
    • A University of Guelph study found that in 2020, as the reality of the pandemic set in, discussions in caremonger groups turned towards difficult topics of social justice, inequality and colonization.
    • One group organizer who took part in the study shared that she felt COVID-19 unveiled the challenges faced by marginalized people.

A more equitable post-pandemic world

    • As the global emergency ends, we need to ask ourselves how a post-pandemic world could be more equitable, just and nurturing.
    • The pandemic allowed people to connect with strangers in their neighbourhoods and country through the development of community good will across different geographies.
    • Pandemic travel restrictions also produced some positive environmental effects around the world.
    • As we reflect on the last three years, let us seize the opportunity to use the experience to create a more equitable, just and nurturing post-pandemic world.

Virtualware partners with Intuita to introduce VIROO in South Korea

Retrieved on: 
Thursday, May 4, 2023
Virtual reality, Assembly, National Fire Agency, Partnership, Education, Firefighter, Ontario Power Generation, Person, VR, EPA, McMaster University, Police, GE Hitachi Nuclear Energy, Torgeir Vraa, Environment, Safety, Tourism, Video game, Risk management

BILBAO, Spain, May 04, 2023 (GLOBE NEWSWIRE) -- Spanish technology company Virtualware (EPA:MLVIR), one of the European leaders in the virtual reality industry, has inked a partnership agreement with Intuita to further introduce VIROO in South Korea.

Key Points: 
  • BILBAO, Spain, May 04, 2023 (GLOBE NEWSWIRE) -- Spanish technology company Virtualware (EPA:MLVIR), one of the European leaders in the virtual reality industry, has inked a partnership agreement with Intuita to further introduce VIROO in South Korea.
  • VIROO was a key focus for participants during a seminar for firefighters and safety professionals organized by Intuita in Daegu, South Korea, on 30 September 2022.
  • The aim of the seminar was to introduce technology trends in firefighting and safety, in particular how to build practical VR training environments.
  • “With multiple industries in Korea looking to use simulation technologies and VR/AR/MR solutions, the interest in these technologies is very high,” commented Sogu Yang, Managing Director of Intuita.

LifeLabs Promotes Dr. Cathy Ross to Vice President of Medical and Quality Affairs, Driving Growth and Quality Healthcare Services Nationwide

Retrieved on: 
Wednesday, May 3, 2023
Abstract, Medicine, Royal college, Master of Science in Quality Management and Analytics, Cancer Care Ontario, Schulich School of Medicine & Dentistry, Safety, Physician, Business, CFB Toronto, Anatomical pathology, Quality, Royal College of Physicians and Surgeons of Canada, McMaster University, Pathology, Surgeon, Master, Quality assurance, Growth, Schulich School of Business, Hospital Insurance and Diagnostic Services Act, Patient safety, Complex, Medical device, Management, Science, List of pathologists

Dr. Ross's appointment marks an exciting new chapter in LifeLabs' growth story and underscores its commitment to building strong relationships and delivering high-quality healthcare services.

Key Points: 
  • Dr. Ross's appointment marks an exciting new chapter in LifeLabs' growth story and underscores its commitment to building strong relationships and delivering high-quality healthcare services.
  • "We are thrilled to have Dr. Cathy Ross leading our Med-Sci and Quality teams," said Charles Brown, CEO of LifeLabs.
  • "During her time with LifeLabs, Dr. Ross has built trusted relationships internally and externally and clearly understands LifeLabs' customers' needs.
  • As Vice President of Medical and Quality Affairs, Dr. Ross will oversee LifeLabs' Medical Science and Quality teams nationwide, playing a critical role in its operations and supporting LifeLabs' strategic objectives.

Media Advisory – the Pros/Cons of Artificial Intelligence – Dr. John Yawney, Chief Analytics Office, Adastra

Retrieved on: 
Wednesday, May 3, 2023
Data Management, Apps, Applications, Technology, Software, Networks, Artificial Intelligence, Internet, Workforce, Problem solving, University, Mathematics, Fear, Research, Organization, Explainable artificial intelligence, McMaster University, Rigid analytic space, Artificial intelligence, Adastra, Hinton, Robotics, Social responsibility, Safety, Medical device, AI

Operational efficiencies – Many businesses have had enormous successes in using AI to increase product quality to profitability through greater efficiencies.

Key Points: 
  • Operational efficiencies – Many businesses have had enormous successes in using AI to increase product quality to profitability through greater efficiencies.
  • From improvements in warehouse safety, supply chain management and product quality indexes and more, AI has contributed vast improvements to many organizations.
  • Model explainability can also allude to new relationships between decisions and decision support variables that may not be immediately evident.
  • Dr. John Yawney, Chief Analytics Officer at Adastra, has executive oversight of the Data Science Practice, leads the development of the AI solutions portfolio, and holds Adjunct Professor status at McMaster University.

RYALTRIS®, a new combination prescription nasal spray for moderate to severe seasonal allergic rhinitis (SAR), now available across Canada

Retrieved on: 
Wednesday, May 3, 2023
Rhinitis, Bausch Health, Senior, QC, SAR, Department of Medicine – University of Pamplona, Olopatadine, BHC, Allergy, Allergen, McMaster University, Division, Allergic rhinitis, Sneeze, TSX, Health Canada, NYSE, Vaccine, Pharmaceutical industry

"The launch of this new therapy adds to our broad portfolio of treatments that further establishes Bausch Health as a trusted partner in the healthcare of Canadians."

Key Points: 
  • "The launch of this new therapy adds to our broad portfolio of treatments that further establishes Bausch Health as a trusted partner in the healthcare of Canadians."
  • "Allergic rhinitis is a common disorder that often doesn't respond adequately to usual treatments" said Dr. Paul Keith, Professor, Division of Clinical Immunology and Allergy, Department of Medicine, McMaster University.
  • "Nasal congestion, nasal itch, runny nose and sneezing are classic symptoms of the disorder.
  • The onset of action for nasal symptom relief occurs within 15 minutes after administration of RYALTRIS.1

Fusion Pharmaceuticals Announces Opening of Radiopharmaceutical Manufacturing Facility to Produce Targeted Alpha Therapies for Cancer

Retrieved on: 
Tuesday, May 2, 2023
GMP, McMaster Innovation Park, Commercialization, Partnership, Biotechnology, Fusion, Research, McMaster, Radiopharmaceutical, Cardinal Health, CDMO, McMaster University, Investment, Tat, Pharmaceutical industry

HAMILTON, ON, May 2, 2023 /PRNewswire/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, today announced the opening of its state-of-the-art radiopharmaceutical manufacturing facility. The 27,000 square foot good manufacturing practice (GMP) compliant facility, which is located adjacent to the Company's research and development labs, has clinical and commercial manufacturing scale capabilities designed to support the Company's growing pipeline of targeted alpha therapies (TATs).

Key Points: 
  • HAMILTON, ON, May 2, 2023 /PRNewswire/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, today announced the opening of its state-of-the-art radiopharmaceutical manufacturing facility.
  • The 27,000 square foot good manufacturing practice (GMP) compliant facility, which is located adjacent to the Company's research and development labs, has clinical and commercial manufacturing scale capabilities designed to support the Company's growing pipeline of targeted alpha therapies (TATs).
  • "Manufacturing and supply chain are critical components of radiopharmaceutical development and commercialization.
  • The new manufacturing facility, part of a 15-year lease agreement with Hamilton, Ontario-based McMaster University, was built by McMaster and equipped and validated by Fusion.

Asthma Canada calls on policy makers to ensure Canadians have access to high-quality respiratory care, when and where they need it

Retrieved on: 
Tuesday, May 2, 2023
Pressure, Tobacco Products Scientific Advisory Committee, Medicine, Asthma, Allergy, Asthma & Immunology Research, Policy, World Asthma Day, Quality of life, SABA, Allergist, Asthma Canada, Pharmacist, Professor, McMaster University, Patient, Division, Nursing, Map, Diagnosis, Research, Letter, Caregiver, Pharmaceutical industry

A recent study Asthma Canada participated in shows high consensus for Canadians living with asthma and severe asthma to have access to specialist care within the optimal period of 4-8 weeks.

Key Points: 
  • A recent study Asthma Canada participated in shows high consensus for Canadians living with asthma and severe asthma to have access to specialist care within the optimal period of 4-8 weeks.
  • We need concerted action to ensure all Canadians living with asthma have access to the quality and timely care they need."
  • For nearly 50 years, Asthma Canada has proudly served as the national voice for Canadians living with asthma.
  • This World Asthma Canada Day we are calling on policy makers to make asthma care a priority and act on the recommendations for high-quality care in the consensus statements study .

Government of Canada Supports Research to Improve Brain Health

Retrieved on: 
Friday, April 28, 2023
Epilepsy, Partnership, Depression, University, The Honourable, Bipolar disorder, Health Canada, Disability studies, Brain, Research, Government, Montreal Neurological Institute and Hospital, Parkinson's disease, McMaster University, Myenteric plexus, Collection, Patient, St. Joseph's Healthcare Hamilton, Local government in Canada, Knowledge, Diagnosis, Mental health, Alzheimer's disease, Minister responsible for the Federal Economic Development Initiative for Northern Ontario, Medical device, Mobile phone, Health

The Government of Canada recognizes the importance of supporting the neuroscience community and its role in improving Canadians' brain health.

Key Points: 
  • The Government of Canada recognizes the importance of supporting the neuroscience community and its role in improving Canadians' brain health.
  • This funding is made possible through Health Canada's Canada Brain Research Fund (CBRF) Program, which has to date committed an overall federal investment of $200 million to Brain Canada Foundation in support of brain health discoveries.
  • "The Government of Canada recognizes the importance of supporting the neuroscience community and brain research as it plays a critical role in increasing our understanding of brain health conditions.
  • Brain Canada shapes its research priorities by engaging with the neuroscience community and bringing research stakeholders together to discuss and advance key brain health issues and opportunities in the health sector.

KAPOOSE CREEK SHARPENS STRATEGIC FOCUS ON GROWTH OPPORUNITIES IN DRUG DISCOVERY AND DEVELOPMENT

Retrieved on: 
Tuesday, April 25, 2023
Amgen, GSK plc, Laboratory, Partnership, Marketing, Regulated Activation Networks, Biogen, Abbott Laboratories, Pfizer, Medicine, Fungus, AstraZeneca, ORA, McMaster University, Nature, United States Department of the Army, Drug discovery, Jazz Pharmaceuticals, Brown, Growth, Ecosystem, Health, FDA, Woman, Pharmaceutical industry

VANCOUVER, BC, April 25, 2023 /CNW/ - Kapoose Creek Wellness today announced a sharpened strategic focus on drug discovery and development, along with the appointment of three outstanding new directors to support the company's growth in the sector.

Key Points: 
  • VANCOUVER, BC, April 25, 2023 /CNW/ - Kapoose Creek Wellness today announced a sharpened strategic focus on drug discovery and development, along with the appointment of three outstanding new directors to support the company's growth in the sector.
  • Working in partnership with McMaster University, we have developed a platform that revolutionizes drug discovery from nature.
  • Kapoose Creek's drug discovery platform – unEarth Rx – is purpose-built to overcome historic limitations of natural product drug discovery.
  • "Following a comprehensive review with our new directors, Kapoose Creek is moving ahead with confidence and a sharpened strategic focus on building a leading-edge drug discovery company," said Dr. Brown.